A young athlete, just 24 years old, sat in my exam room, frustrated
Food and Drug Administration (2023) Examining off-label prescribing of Ozempic for weight loss, Qeios (2023) Wegovy (semaglutide): a new weight loss drug for chronic weight management, Journal of Investigative Medicine (2022) Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-week, open-label, randomized clinical trial, Diabetes Care (2018) Clinical insight on semaglutide for chronic weight management in adults: patient selection and special considerations, Drug Design, Development and Therapy (2022) Semaglutide, MedlinePlus (2023) Clinical insight on semaglutide for chronic weight management in adults: Patient selection and special considerations, Drug Design, Development and Therapy (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

KPV may offer an alternative by delivering TNF-alpha suppression directly to the GI tract without the need for invasive injections
Actin is the most abundant intracellular protein
Reported side effects of BPC 157 are minimal, with some individuals experiencing temporary discomfort at the injection site